title: Cost-effectiveness--can it be measured?
authors.affiliation: Program for the Analysis of Clinical Strategies, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: R L
authors.initials: RL
authors.lastname: Bohn
authors.forename: J
authors.initials: J
authors.lastname: Avorn
mesh_terms: D003362:Cost-Benefit Analysis; D005169:Factor VIII / Q000008:administration & dosage / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D007592:Joint Diseases / Q000209:etiology / Q000517:prevention & control*; D009316:National Institutes of Health (U.S.); D014481:United States
chemical_list: D005169:Factor VIII